Alvotech

Contributing Author

Recent Articles by Alvotech

Jun-02	Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY ALVO GlobeNewswire
Jun-02	Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY ALVO GlobeNewswire
May-28	Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe ALVO GlobeNewswire
May-28	Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe ALVO GlobeNewswire
May-26	Alvotech Annual General Meeting to be held June 25, 2025 ALVO GlobeNewswire
May-23	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
May-19	Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm ALVO GlobeNewswire
May-19	Trading in Alvotech's Shares on Nasdaq Stockholm Commences Today ALVO GlobeNewswire
May-16	Alvotech Announces the Outcome of the Offering in Connection with the Company's Listing on Nasdaq Stockholm ALVO GlobeNewswire
May-16	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
May-13	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
May-09	Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada ALVO GlobeNewswire
May-09	Alvotech Meets Investors and Participates in Fireside Chat At the BofA Securities Healthcare Conference 2025 in Las Vegas, Nevada ALVO GlobeNewswire
May-09	Transactions of Managers and Closely Associated Persons ALVO GlobeNewswire
May-08	Alvotech Publishes Prospectus in Connection with its Listing on Nasdaq Stockholm ALVO GlobeNewswire
May-07	Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update ALVO GlobeNewswire
May-07	Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update ALVO GlobeNewswire
May-07	Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025 ALVO GlobeNewswire
May-07	Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025 ALVO GlobeNewswire
May-05	Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with Stelara (ustekinumab) ALVO GlobeNewswire
May-05	Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI (ustekinumab-aekn) with Stelara (ustekinumab) ALVO GlobeNewswire
May-02	Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT (14:00 CET) ALVO GlobeNewswire
May-02	Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT ALVO GlobeNewswire

Alvotech

Recent Articles by Alvotech

Upgrade your FINVIZ experience